Cargando…
Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19
INTRODUCTION: The study aim was to assess the influence of inflammatory response modifiers, including anti-interleukin-6 (IL-6) biologics and corticosteroids, on the incidence of hospital-acquired infections in patients with coronavirus disease 2019 (COVID-19). METHODS: Case–control study performed...
Autores principales: | Meira, Fernanda, Moreno-García, Estela, Linares, Laura, Macaya, Irene, Tomé, Adria, Hernández-Meneses, Marta, Albiach, Laia, Morata, Laura, Letona, Laura, Bodro, Marta, Cózar-Llistó, Alberto, Cardozo, Celia, Chumbita, Mariana, Pitart, Cristina, Ambrosioni, Juan, Rico, Verónica, Agüero, Daiana, Puerta-Alcalde, Pedro, Garcia-Pouton, Nicole, Marco, Francesc, Garcia-Vidal, Carolina, Soriano, Alex, Martínez, José Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193595/ https://www.ncbi.nlm.nih.gov/pubmed/34115314 http://dx.doi.org/10.1007/s40121-021-00477-9 |
Ejemplares similares
-
Experience with the use of siltuximab in patients with SARS-CoV-2 infection
por: Meira, Fernanda, et al.
Publicado: (2021) -
Real-life use of remdesivir in hospitalized patients with COVID-19
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021) -
Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
por: Inciarte, Alexy, et al.
Publicado: (2021) -
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
por: Garcia-Vidal, Carolina, et al.
Publicado: (2021) -
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection
por: Moreno-García, Estela, et al.
Publicado: (2021)